Trials / Unknown
UnknownNCT03658850
Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients
Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
HYDRA is a randomized clinical trial designed to evaluate safety and efficiency of hydrochlorothiazide in critical patients with hypernatremia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrochlorothiazide 50Mg | for the experimental group received a hydrochlorothiazide tablet on presentation of 50mg or equivalent enteral solution every 12h (total of 100mg per day) enterally on day 0 (D0) until day 3 |
| DRUG | Placebos | for the placebo group will receive one tablet or equivalent volume of enteral solution of inert substance, identical to the hydrochlorothiazide presentations, every 12 hours until day 3 |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-12-10
- Completion
- 2020-03-10
- First posted
- 2018-09-05
- Last updated
- 2019-04-30
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03658850. Inclusion in this directory is not an endorsement.